SEC 13F Intelligence

Thompson Siegel & Walmsley LLC / MRK

Thompson Siegel & Walmsley LLC’s Merck & Co Inc Position

Does Thompson Siegel & Walmsley LLC own Merck & Co Inc (MRK)? Yes — 274.7K shares worth $33M (+0.58% of its 13F portfolio) as of Q1 2026, down from 301.9K shares the prior filed quarter.

Position Value
$33M
Q1 2026
Shares
274.7K
% of Portfolio
+0.58%
Quarters Held
30
currently held

Position History MRK

Reported value by quarter
Q4 ’18: $9MQ4 ’18Q1 ’19: $10MQ2 ’19: $10MQ3 ’19: $10MQ4 ’19: $12MQ4 ’19Q1 ’20: $10MQ2 ’20: $14MQ3 ’20: $17MQ4 ’20: $19MQ4 ’20Q1 ’21: $23MQ2 ’21: $25MQ3 ’21: $24MQ4 ’21: $25MQ4 ’21Q1 ’22: $31MQ2 ’22: $27MQ3 ’22: $26MQ4 ’22: $30MQ4 ’22Q1 ’23: $28MQ2 ’23: $30MQ3 ’23: $27MQ4 ’23: $28MQ4 ’23Q1 ’24: $33MQ2 ’24: $31MQ3 ’24: $28MQ4 ’24: $25MQ4 ’24Q1 ’25: $24MQ2 ’25: $23MQ3 ’25: $25MQ4 ’25: $32MQ4 ’25Q1 ’26: $33Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026274.7K$33M+0.58%
Q4 2025301.9K$32M+0.53%
Q3 2025302.4K$25M+0.41%
Q2 2025285.3K$23M+0.38%
Q1 2025272.4K$24M+0.41%
Q4 2024246.4K$25M+0.38%
Q3 2024248.1K$28M+0.42%
Q2 2024249.2K$31M+0.49%
Q1 2024250.6K$33M+0.51%
Q4 2023254.5K$28M+0.45%
Q3 2023259.9K$27M+0.44%
Q2 2023259.3K$30M+0.48%
Q1 2023265.5K$28M+0.46%
Q4 2022271.1K$30M+0.49%
Q3 2022298.5K$26M+0.44%
Q2 2022300.3K$27M+0.44%
Q1 2022372.7K$31M+0.44%
Q4 2021326.7K$25M+0.34%
Q3 2021323.0K$24M+0.35%
Q2 2021321.0K$25M+0.34%
Q1 2021304.5K$23M+0.33%
Q4 2020227.9K$19M+0.30%
Q3 2020207.4K$17M+0.33%
Q2 2020183.3K$14M+0.29%
Q1 2020131.3K$10M+0.24%
Q4 2019127.2K$12M+0.18%
Q3 2019116.8K$10M+0.16%
Q2 2019118.1K$10M+0.14%
Q1 2019117.9K$10M+0.14%
Q4 2018118.2K$9M+0.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Thompson Siegel & Walmsley LLC’s full portfolio or all institutional holders of MRK.